A fundamental restructuring of the nation's elder care framework is currently underway, driven by a confluence of deregulatory actions and technological experiments that promises to redefine the experiences of millions of older Americans, their families, and the professionals who care for
While the European Union champions circular economies and aggressive climate targets in nearly every sector, its operating rooms have paradoxically remained bastions of a throwaway culture, generating mountains of medical waste from devices designed for a single use. For decades, the reprocessing
Navigating End-of-Life Choices: The New York Medical Aid in Dying Act A profound shift in the conversation surrounding end-of-life autonomy has arrived in New York, as Governor Kathy Hochul has officially signed the amended Medical Aid in Dying Act into law. This landmark legislation, the result of
After years of escalating pressure and legislative debate, the Consolidated Appropriations Act of 2026 has finally landed, bringing with it a wave of reforms aimed at the powerful and often opaque world of Pharmacy Benefit Managers (PBMs). Employer groups, representing the health plans of more than
The quest for a safer method to prevent strokes has long been a paramount challenge in cardiovascular medicine, as current treatments often force a difficult trade-off between preventing blood clots and risking severe bleeding. In this high-stakes environment, a new class of anticoagulants known as
I'm joined today by Faisal Zain, a leading expert in U.S. healthcare policy with deep insights into hospital finance and pharmaceutical pricing. We're here to unpack the recent, and for many, welcome decision by the Department of Health and Human Services to scrap its controversial 340B
